Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |